Tavistock study reveals new insights about puberty blockers

17 Dec 2020


A study that began in 2011, run by the Tavistock’s Gender Identity Development Service, reveals that 98% of children treated for gender dysphoria with puberty blockers at the Tavistock Centre, also went on to take cross-sex hormones.

BBC News


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story